Gut Microbiota, the Potential Biological Medicine for Prevention, Intervention and Drug Sensitization to Fight Diseases

As the largest “immune organ” of human beings, the gut microbiota is symbiotic and mutually beneficial with the human host, playing multiple physiological functions. Studies have long shown that dysbiosis of gut microbiota is associated with almost all human diseases, mainly including type II diabet...

Full description

Bibliographic Details
Main Authors: Haijie Wu, Xiaoguang Chen, Sen Zhang, Jiaxin Li
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/14/20/4220
_version_ 1797470696560918528
author Haijie Wu
Xiaoguang Chen
Sen Zhang
Jiaxin Li
author_facet Haijie Wu
Xiaoguang Chen
Sen Zhang
Jiaxin Li
author_sort Haijie Wu
collection DOAJ
description As the largest “immune organ” of human beings, the gut microbiota is symbiotic and mutually beneficial with the human host, playing multiple physiological functions. Studies have long shown that dysbiosis of gut microbiota is associated with almost all human diseases, mainly including type II diabetes, cancers, neurodegenerative diseases, autism spectrum disorder, and kidney diseases. As a novel and potential biological medicine for disease prevention, intervention and drug sensitization, the gut microbiota has attracted more and more attention recently. Although the gut microbiota is a comprehensive microbial community, several star bacteria have emerged as possible tools to fight against various diseases. This review aims to elucidate the relevance of gut microbiota dysbiosis with disease occurrence and progression, and mainly summarizes four well-known genera with therapeutic and sensitizing potential, <i>Akkermansia</i>, <i>Bifidobacterium</i>, <i>Lactobacillus</i> and <i>Parabacteroides</i>, thoroughly elucidate their potential value as biological drugs to treat diverse disease.
first_indexed 2024-03-09T19:39:43Z
format Article
id doaj.art-b3b444aa7c814233ac828a76e2967106
institution Directory Open Access Journal
issn 2072-6643
language English
last_indexed 2024-03-09T19:39:43Z
publishDate 2022-10-01
publisher MDPI AG
record_format Article
series Nutrients
spelling doaj.art-b3b444aa7c814233ac828a76e29671062023-11-24T01:42:39ZengMDPI AGNutrients2072-66432022-10-011420422010.3390/nu14204220Gut Microbiota, the Potential Biological Medicine for Prevention, Intervention and Drug Sensitization to Fight DiseasesHaijie Wu0Xiaoguang Chen1Sen Zhang2Jiaxin Li3State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, ChinaState Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, ChinaState Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, ChinaDepartment of Gastrointestinal Surgery, The Sixth Affiliated Hospital of Wenzhou Medical University & Lishui City People’s Hospital, Lishui 323000, ChinaAs the largest “immune organ” of human beings, the gut microbiota is symbiotic and mutually beneficial with the human host, playing multiple physiological functions. Studies have long shown that dysbiosis of gut microbiota is associated with almost all human diseases, mainly including type II diabetes, cancers, neurodegenerative diseases, autism spectrum disorder, and kidney diseases. As a novel and potential biological medicine for disease prevention, intervention and drug sensitization, the gut microbiota has attracted more and more attention recently. Although the gut microbiota is a comprehensive microbial community, several star bacteria have emerged as possible tools to fight against various diseases. This review aims to elucidate the relevance of gut microbiota dysbiosis with disease occurrence and progression, and mainly summarizes four well-known genera with therapeutic and sensitizing potential, <i>Akkermansia</i>, <i>Bifidobacterium</i>, <i>Lactobacillus</i> and <i>Parabacteroides</i>, thoroughly elucidate their potential value as biological drugs to treat diverse disease.https://www.mdpi.com/2072-6643/14/20/4220gut microbiota<i>Akkermansia</i><i>Bifidobacterium</i><i>Lactobacillus</i><i>Parabacteroides</i>cancer
spellingShingle Haijie Wu
Xiaoguang Chen
Sen Zhang
Jiaxin Li
Gut Microbiota, the Potential Biological Medicine for Prevention, Intervention and Drug Sensitization to Fight Diseases
Nutrients
gut microbiota
<i>Akkermansia</i>
<i>Bifidobacterium</i>
<i>Lactobacillus</i>
<i>Parabacteroides</i>
cancer
title Gut Microbiota, the Potential Biological Medicine for Prevention, Intervention and Drug Sensitization to Fight Diseases
title_full Gut Microbiota, the Potential Biological Medicine for Prevention, Intervention and Drug Sensitization to Fight Diseases
title_fullStr Gut Microbiota, the Potential Biological Medicine for Prevention, Intervention and Drug Sensitization to Fight Diseases
title_full_unstemmed Gut Microbiota, the Potential Biological Medicine for Prevention, Intervention and Drug Sensitization to Fight Diseases
title_short Gut Microbiota, the Potential Biological Medicine for Prevention, Intervention and Drug Sensitization to Fight Diseases
title_sort gut microbiota the potential biological medicine for prevention intervention and drug sensitization to fight diseases
topic gut microbiota
<i>Akkermansia</i>
<i>Bifidobacterium</i>
<i>Lactobacillus</i>
<i>Parabacteroides</i>
cancer
url https://www.mdpi.com/2072-6643/14/20/4220
work_keys_str_mv AT haijiewu gutmicrobiotathepotentialbiologicalmedicineforpreventioninterventionanddrugsensitizationtofightdiseases
AT xiaoguangchen gutmicrobiotathepotentialbiologicalmedicineforpreventioninterventionanddrugsensitizationtofightdiseases
AT senzhang gutmicrobiotathepotentialbiologicalmedicineforpreventioninterventionanddrugsensitizationtofightdiseases
AT jiaxinli gutmicrobiotathepotentialbiologicalmedicineforpreventioninterventionanddrugsensitizationtofightdiseases